Dismissal of Prevagen case deals tough blow to FTC

When the Federal Trade Commission and New York’s attorney general joined forces to sue Quincy Bioscience for deceptive advertising in promoting Prevagen, a dietary supplement, the enforcers came out guns blazing.

Jessica Rich, then the director of the Bureau of Consumer Protection, blasted the company for making false and unsubstantiated claims